The Biden administration announced Thursday that drug companies receiving research funding from HHS’ emergency response arm, the Administration for Strategic Preparedness and Response, will have to commit to a “fair price” – not more than they charge in other countries. Host Chelsea Cirruzzo talks with POLITICO health care reporter Robert King about the Biden administration's efforts to curb high prescription drug prices.    

Learn more about your ad choices. Visit megaphone.fm/adchoices

Rss Apple Podcaster
Podden och tillhörande omslagsbild på den här sidan tillhör POLITICO. Innehållet i podden är skapat av POLITICO och inte av, eller tillsammans med, Poddtoppen.